[1]. Akemi J Tanaka, et al. Mutations in SPATA5 Are Associated with Microcephaly, Intellectual Disability, Seizures, and Hearing Loss. Am J Hum Genet. 2015 Sep 3;97(3):457-64.  [Content Brief]

[2]. Àngels García-Cazorla, et al. Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome. Acta Neuropathol. 2020 Dec;140(6):971-975.  [Content Brief]

[3]. Björn Fischer-Zirnsak, et al. Haploinsufficiency of the Notch Ligand DLL1 Causes Variable Neurodevelopmental Disorders. Am J Hum Genet. 2019 Sep 5;105(3):631-639.  [Content Brief]

[4]. Ethiraj Ravindran, et al. Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation. PLoS Genet. 2017 Apr 28;13(4):e1006746.  [Content Brief]

[5]. Francesca Mattioli, et al. De Novo Frameshift Variants in the Neuronal Splicing Factor NOVA2 Result in a Common C-Terminal Extension and Cause a Severe Form of Neurodevelopmental Disorder. Am J Hum Genet. 2020 Apr 2;106(4):438-452.  [Content Brief]

[6]. Ideke J C Lamers, et al. Recurrent De Novo Mutations Disturbing the GTP/GDP Binding Pocket of RAB11B Cause Intellectual Disability and a Distinctive Brain Phenotype. Am J Hum Genet. 2017 Nov 2;101(5):824-832.  [Content Brief]

[7]. Ingrid Paine, et al. Paralog Studies Augment Gene Discovery: DDX and DHX Genes. Am J Hum Genet. 2019 Aug 1;105(2):302-316.  [Content Brief]

[8]. Kelly Schoch, et al. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay. Am J Hum Genet. 2017 Feb 2;100(2):343-351.  [Content Brief]

[9]. Konrad Platzer, et al. De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies. Am J Hum Genet. 2019 Feb 7;104(2):203-212.  [Content Brief]

[10]. Linyan Meng, et al. MED27 Variants Cause Developmental Delay, Dystonia, and Cerebellar Hypoplasia. Ann Neurol. 2021 Apr;89(4):828-833.  [Content Brief]

[11]. Nicole J Van Bergen, et al. Deficiencies in vesicular transport mediated by TRAPPC4 are associated with severe syndromic intellectual disability. Brain. 2020 Jan 1;143(1):112-130.  [Content Brief]

[12]. Renske Oegema, et al. Human mutations in integrator complex subunits link transcriptome integrity to brain development. PLoS Genet. 2017 May 25;13(5):e1006809.  [Content Brief]

[13]. Robert Smigiel, et al. Developmental epileptic encephalopathy with hypomyelination and brain atrophy associated with PTPN23 variants affecting the assembly of UsnRNPs. Eur J Hum Genet. 2018 Oct;26(10):1502-1511.  [Content Brief]

[14]. Sara Reynhout, et al. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders. Am J Hum Genet. 2019 Jan 3;104(1):139-156.  [Content Brief]

[15]. Siddharth Srivastava, et al. BRAT1 mutations present with a spectrum of clinical severity. Am J Med Genet A. 2016 Sep;170(9):2265-73.  [Content Brief]

[16]. Volkan Okur, et al. De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment. Eur J Hum Genet. 2019 Jul;27(7):1081-1089.  [Content Brief]